80 related articles for article (PubMed ID: 18180438)
1. Evidence for a complex interaction between HLA-DRB1 and environmental factors in MS.
Fontaine B; Barcellos LF
Neurology; 2008 Jan; 70(2):97-8. PubMed ID: 18180438
[No Abstract] [Full Text] [Related]
2. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
[TBL] [Abstract][Full Text] [Related]
3. HLA-DRB1*15, low infant sibling exposure, and multiple sclerosis gene-environment interaction.
Ramagopalan SV; Dyment DA; Giovannoni G; Sadovnick AD; Ebers GC
Ann Neurol; 2010 May; 67(5):694-5. PubMed ID: 20437569
[No Abstract] [Full Text] [Related]
4. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.
Chao MJ; Ramagopalan SV; Herrera BM; Lincoln MR; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2009 Jan; 18(2):261-6. PubMed ID: 19098025
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis.
Ramagopalan SV; Hanwell HE; Giovannoni G; Knappskog PM; Nyland HI; Myhr KM; Ebers GC; Torkildsen O
Arch Neurol; 2010 Aug; 67(8):1034-5. PubMed ID: 20697062
[No Abstract] [Full Text] [Related]
6. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
Ramagopalan SV; Byrnes JK; Dyment DA; Guimond C; Handunnetthi L; Disanto G; Yee IM; Ebers GC; Sadovnick AD
J Hum Genet; 2009 Sep; 54(9):547-9. PubMed ID: 19629136
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
8. HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis.
Cournu-Rebeix I; Génin E; Leray E; Babron MC; Cohen J; Gout C; Alizadeh M; Perdry H; Semana G; Brassat D; Clerget-Darpoux F; Yaouanq J; Edan G; Rosenheim M; Fontaine B
Genes Immun; 2008 Sep; 9(6):570-4. PubMed ID: 18615093
[TBL] [Abstract][Full Text] [Related]
9. Re: HLA-DRB1 and multiple sclerosis in Malta.
Ramagopalan SV; Dyment DA; Sadovnick AD; Ebers GC
Neurology; 2008 Oct; 71(17):1379. PubMed ID: 18936434
[No Abstract] [Full Text] [Related]
10. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility.
Fernandez-Morera JL; Rodriguez-Rodero S; Tunon A; Martinez-Borra J; Vidal-Castineira JR; Lopez-Vazquez A; Rodrigo L; Rodrigo P; González S; Lahoz CH; Lopez-Larrea C
Tissue Antigens; 2008 Jul; 72(1):54-9. PubMed ID: 18588574
[TBL] [Abstract][Full Text] [Related]
11. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR.
Zivković M; Stanković A; Dincić E; Popović M; Popović S; Raicević R; Alavantić D
Clin Chim Acta; 2009 Aug; 406(1-2):27-30. PubMed ID: 19433080
[TBL] [Abstract][Full Text] [Related]
12. HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosis.
Imrell K; Greiner E; Hillert J; Masterman T
J Neuroimmunol; 2009 May; 210(1-2):128-30. PubMed ID: 19327846
[TBL] [Abstract][Full Text] [Related]
13. The role of vitamin D in multiple sclerosis.
Kampman MT; Steffensen LH
J Photochem Photobiol B; 2010 Nov; 101(2):137-41. PubMed ID: 20471852
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 and multiple sclerosis: the A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
Wray BN; Stankovich J; Whittock L; Dwyer T; Ponsonby AL; van der Mei IA; Taylor B; Dickinson J; Foote S; McMorran BJ
J Neuroimmunol; 2008 May; 196(1-2):139-42. PubMed ID: 18378005
[TBL] [Abstract][Full Text] [Related]
15. Ireland: a fine place for multiple sclerosis research.
Taylor BV
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):237. PubMed ID: 21325022
[No Abstract] [Full Text] [Related]
16. Multiple sclerosis associates with LILRA3 deletion in Spanish patients.
Ordóñez D; Sánchez AJ; Martínez-Rodríguez JE; Cisneros E; Ramil E; Romo N; Moraru M; Munteis E; López-Botet M; Roquer J; García-Merino A; Vilches C
Genes Immun; 2009 Sep; 10(6):579-85. PubMed ID: 19421224
[TBL] [Abstract][Full Text] [Related]
17. Diet and nutrition: vitamin D regulates MS gene.
Potera C
Environ Health Perspect; 2009 May; 117(5):A196. PubMed ID: 19478983
[No Abstract] [Full Text] [Related]
18. An overview of gene-epigenetic-environmental contributions to MS causation.
Lincoln JA; Cook SD
J Neurol Sci; 2009 Nov; 286(1-2):54-7. PubMed ID: 19616791
[TBL] [Abstract][Full Text] [Related]
19. Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
Ganesvaran G; Greer JM; Pender MP
Mult Scler; 2009 Jun; 15(6):763-6. PubMed ID: 19482865
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR15 and age at onset in multiple sclerosis.
Masterman T; Hillert J
Eur J Neurol; 2002 Mar; 9(2):179-80. PubMed ID: 11882062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
